To accelerate breakthroughs, the Damon Runyon Foundation provides today's best young scientists with funds to pursue innovative cancer research.

Daniel Schmidt, PhD
Dr. Schmidt [Norman B. Leventhal Fellow] focuses on the brain cancer glioblastoma multiforme, one of the most malignant, invasive and difficult-to-treat brain tumors. He aims to develop innovative research tools (bioengineered molecules) to investigate the role of critical proteins, ion channels, in glioblastoma growth and metastasis. These findings will lead to a better understanding of how ion channel disorders contribute to cancer development. Ion channels may represent new targets for cancer therapy.
Project Title: "Molecular-targeted reagents to probe the role of ion channels in glioblastoma oncogenesis, proliferation, and migration"
Institution: Massachusetts Institute of Technology
Sponsor(s) / Mentor(s): Edward S. Boyden, PhD
Cancer Type: Brain, Neuro-oncology
Research Area: Biomedical Engineering


